药物成瘾及成瘾记忆的研究现状

本文在介绍药物成瘾与学习和记忆密切相关的神经回路及共同分子机制的基础上,围绕学习和记忆在药物成瘾中的作用,综述了关联性学习与复吸,关联性学习与敏化,异常关联性学习与强迫性用药行为,关联性学习及成瘾记忆与成瘾,多重记忆系统与成瘾的发生发展等方面的研究进展,并强调了突触可塑性及成瘾记忆在药物成瘾中的重要性。在此基础上提出：作为慢性脑病的药物成瘾的形成过程的重要特征是它包含着信息的特殊学习类型。药物成瘾与依赖于多巴胺的关联性学习紊乱有密切关系。海马可能在成瘾中扮演重要角色。     

钙神经素与学习和记忆

钙神经素 (calcineurin ,CN)是一种钙依赖的蛋白磷酸酶 ,其催化亚基的基因编码具严格保守性。近年来研究证明其在学习和记忆中有重要作用 ,参与了大脑神经元突触效应的去增强、多种不同机制的长时程抑制 (LTD)、长时程增强 (LTP)、认知记忆、短期记忆向长期记忆的转换、脑老化等过程。深入研究CN参与学习和记忆的机制及其与记忆减退性疾病的关系 ,具有重要理论与实践意义     

学习与记忆神经机制研究进展

学习与记忆是大脑的重要高级功能,认知神经科学的迅速发展为探索学习与记忆的神经机制提供了新的思路和方法。突触的可塑性变化可能是记忆形成与巩固的分子与细胞机制,随着神经联结的形成,大脑构建出不同的记忆通路,不同类型的记忆又享有各自的记忆系统。对记忆的脑机制研究能够指导人们如何有效地提高记忆。论述了记忆的形成与巩固的神经机制,脑的记忆系统以及如何有效地提高记忆成绩。     

学习与记忆的机制简介

学习和记忆是动物中枢神经系统高级活动的一种方式,也是动物赖以生存和进化发展的关键。对学习和记忆机制的研究,积累了大量资料,主要体现在神经生理和生物化学两个方面。１学习与记忆的脑功能定位尽管学习记忆涉及整个脑的广泛变化,但某些特殊的区域和环路与学习记忆...     

若干有关学习和记忆神经机制问题的讨论

若干有关学习和记忆神经机制问题的讨论梅镇彤（中国科学院上海生理研究所,上海２０００３１）目录一、学习和记忆的分类问题二、突触可塑性与学习记忆三、运动学习记忆的神经基础四、长时记忆分子生物学研究的新进展五、结束语学习和记忆是脑的重要功能,关于学习和记忆...     

学习和记忆的神经生化学机制的研究概况

脑功能研究是生物科学界当前最重要课题之一,学习和记忆是大脑高级功能之一,本文就各种神经递质和神经活性肽对学习记忆的作用进行综述,以便促进改善于学习和记忆功能方面的课题研究了广泛开展。     

鸟类发声学习记忆研究进展

鸟类发声学习记忆研究进展李东风,蓝书成（东北师范大学生物系神经生物学研究室长春１３００２４）学习与记忆的机制是神经科学领域中颇受重视的研究课题。鸟类的鸣啭被认为是动物语言学习记忆过程。国内外近年来的研究表明,这一过程与人类的语言学习记忆有着许多相似之...     

学习记忆机制研究的简介

本文介绍了无脊椎动物。脊椎动物与人的学习、记忆的不同类型，即简单学习、结合学习、复合学习．记忆过程的神经基础及其神经机理，学习、记忆与神经肽的相关关系，以及学习与记忆的神经分子生物学新进展。     

鸟类学习记忆研究进展

在学习记忆研究中,需根据不同的实验目的选用不同的实验动物和模型。鸟类在生物进化上具有独特的地位,由此决定了其在认知科学研究中的价值。现已建立了呜禽呜唱学习、鸟类空间学习及视觉分辨学习等重要实验模型,并开展了一系列的学习记忆机制研究。文章对近年来鸟类学习记忆研究的进展,从鸟类鸣唱行为、海马功能以及神经递质作用等方面做了回顾。     

学习记忆小动物模型浅议

介绍了几种国内外常用的学习记忆小动物模型的操作方法，并简略介绍了一种国内未见报道的无奖惩效应的改良“十”字迷宫，该动物模型贴近动物自然本色，避免了奖惩效应对学习记忆的影响。     

Alternative roles for Cdk5 in learning and synaptic plasticity

Protein kinases mediate the intracellular signal transduction pathways controlling synaptic plasticity in the central nervous system. While the majority of protein kinases achieve this function via the phosphorylation of synaptic substrates, some kinases may contribute through alternative mechanisms in addition to enzymatic activity. There is growing evidence that protein kinases may often play structural roles in plasticity as well. Cyclin-dependent kinase 5 (Cdk5) has been implicated in learning and synaptic plasticity. Initial scrutiny focused on its enzymatic activity using pharmacological inhibitors and genetic modifications of Cdk5 cofactors. Quite recently Cdk5 has been shown to govern learning and plasticity via regulation of glutamate receptor degradation, a function that may not dependent on phosphorylation of downstream effectors. From these new studies, two roles emerge for Cdk5 in plasticity: one in which it controls structural plasticity via phosphorylation of synaptic substrates, and a second where it regulates functional plasticity via protein-protein interactions.     

Cdk5在可卡因诱导的药物成瘾中的作用

细胞周期素依赖性蛋白激酶5(cyclin dependent kinase-5,Cdk5)是细胞周期素蛋白激酶之一,具有很多磷酸化底物,其激动剂p35和p39特异存在于神经系统(CNS)。因此,Cdk5在神经系统中的功能尤为突出,成为神经科学研究热点。目前研究较多的是Cdk5在可卡因诱导的药物成瘾中的作用。在可卡因所致药物成瘾过程中,多巴胺系统,ΔFosB,神经元突触可塑性等发挥重要作用。Cdk5与这些分子相互作用,所以,Cdk5与可卡因诱导所致药物成瘾密切相关。阐明其与药物成瘾的联系,探索新的以Cdk5为靶向的药物,将可能成为成瘾治疗的有效手段。综述了在可卡因诱导的药物成瘾中Cdk5作用,以及Cdk5与相关的信号转导分子之间的相互调节。     

Cdk5: a novel role in learning and memory

Learning and memory are processes by which organisms acquire, retain and retrieve information. They result in modifications of behavior in response to new or previously encountered stimuli thereby enabling adaptation to a permanently changing environment. Protein phosphorylation has long been known to play a key role in triggering synaptic changes underlying learning and memory. Although intracellular phosphorylation and dephosphorylation is orchestrated by a complex network of interactions between a number of protein kinases and phosphatases, significant advances in the understanding of neuronal mechanisms underlying learning and memory have been achieved by investigating the actions of individual molecules under defined experimental conditions, brain areas, neuronal cells and their subcellular compartments. On the basis of these approaches, the cyclic AMP protein kinase (PKA), protein kinase C (PKC) and extracellularly regulated protein kinases 1 and 2 (Erk-1/2) have been identified as the core signaling pathways in memory consolidation. Here we review recent findings demonstrating an important novel role for Cdk5 in learning and memory. We suggest that some of the well-characterized roles of Cdk5 during neurodevelopmental processes, such as interactions with distinct cytoplasmic and synaptic target molecules, may be also involved in synaptic plasticity underlying memory consolidation within the adult central nervous system.     

Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5

Normal Cdk5 activity, conferred mainly by association with its primary activator p35, is critical for normal function of the cell and must be tightly regulated. During neurotoxicity, p35 is cleaved to form p25, which becomes a potent and mislocalized hyperactivator of Cdk5, resulting in a deregulation of Cdk5 activity. p25 levels have been found to be elevated in Alzheimer's disease (AD) brain and overexpression of p25 in a transgenic mouse results in the formation of phosphorylated tau, neurofibrillary tangles and cognitive deficits that are pathological hallmarks of AD. p25/Cdk5 also hyperphosphorylates neurofilament proteins that constitute pathological hallmarks found in Parkinson's disease and amyotrophic lateral sclerosis. The selective targeting of p25/Cdk5 activity without affecting p35/Cdk5 activity has been unsuccessful. In this review we detail our recent studies of selective p25/Cdk5 inhibition without affecting p35/Cdk5 or mitotic Cdk activities. We found that a further truncation of p25 to yield a Cdk5 inhibitory peptide (CIP) can specifically inhibit p25/Cdk5 activity in transfected HEK cells and primary cortical neurons. CIP was able to reduce tau hyperphosphorylation and neuronal death induced caused by p25/Cdk5 and further studies with CIP may develop a specific Cdk5 inhibition strategy in the treatment of neurodegeneration.     

Cdk5/p35激酶与肌动蛋白细胞骨架结合关系的鉴定

Cdk5,一种多功能的丝氨酸/苏氨酸蛋白激酶,其活性只有通过结合其神经特异性调节亚基才能被激活.p35是Cdk5的两个主要调节亚基之一.尽管Cdk5/p35激酶可以调控神经细胞中肌动蛋白细胞骨架的动态变化,但直到目前为止Cdk5/p35激酶与肌动蛋白细胞骨架的结合关系仍不是很清楚.现利用几种不同的方法对两者的结合关系进行了初步鉴定.目前的试验结果表明在鼠脑组织中肌动蛋白细胞骨架是Cdk5/p35超大蛋白复合体的一个组分,p35可以直接结合纤维状肌动蛋白,这说明在鼠脑组织或神经细胞中Cdk5很有可能是通过p35结合到肌动蛋白细胞骨架上并进一步调控肌动蛋白细胞骨架的动态活动的.     

The Cdk5 inhibitor Roscovitine increases LTP induction in corticostriatal synapses

In corticostriatal synapses, LTD (long-term depression) and LTP (long-term potentiation) are modulated by the activation of DA (dopamine) receptors, with LTD being the most common type of long-term plasticity induced using the standard stimulation protocols. In particular, activation of the D1 signaling pathway increases cAMP/PKA (protein kinase A) phosphorylation activity and promotes an increase in the amplitude of glutamatergic corticostriatal synapses. However, if the Cdk5 (cyclin-dependent kinase 5) phosphorylates the DARPP-32 (dopamine and cAMP-regulated phosphoprotein of 32 kDa) at Thr⁷⁵, DARPP-32 becomes a strong inhibitor of PKA activity. Roscovitine is a potent Cdk5 inhibitor; it has been previously shown that acute application of Roscovitine increases striatal transmission via Cdk5/DARPP-32. Since DARPP-32 controls long-term plasticity in the striatum, we wondered whether switching off CdK5 activity with Roscovitine contributes to the induction of LTP in corticostriatal synapses. For this purpose, excitatory population spikes and whole cell EPSC (excitatory postsynaptic currents) were recorded in striatal slices from C57/BL6 mice. Experiments were carried out in the presence of Roscovitine (20 μM) in the recording bath. Roscovitine increased the amplitude of excitatory population spikes and the percentage of population spikes that exhibited LTP after HFS (high-frequency stimulation; 100Hz). Results obtained showed that the mechanisms responsible for LTP induction after Cdk5 inhibition involved the PKA pathway, DA and NMDA (N-methyl-D-aspartate) receptor activation, L-type calcium channels activation and the presynaptic modulation of neurotransmitter release.     

Neurodegeneration in an Aβ-induced model of Alzheimer's disease: the role of Cdk5

Cdk5 dysregulation is a major event in the neurodegenerative process of Alzheimer's disease (AD). In vitro studies using differentiated neurons exposed to Aβ exhibit Cdk5-mediated tau hyperphosphorylation, cell cycle re-entry and neuronal loss. In this study we aimed to determine the role of Cdk5 in neuronal injury occurring in an AD mouse model obtained through the intracerebroventricular (icv) injection of the Aβ_1–40 synthetic peptide. In mice icv-injected with Aβ, Cdk5 activator p35 is cleaved by calpains, leading to p25 formation and Cdk5 overactivation. Subsequently, there was an increase in tau hyperphosphorylation, as well as decreased levels of synaptic markers. Cell cycle reactivation and a significant neuronal loss were also observed. These neurotoxic events in Aβ-injected mice were prevented by blocking calpain activation with MDL28170 , which was administered intraperitoneally (ip). As MDL prevents p35 cleavage and subsequent Cdk5 overactivation, it is likely that this kinase is involved in tau hyperphosphorylation, cell cycle re-entry, synaptic loss and neuronal death triggered by Aβ. Altogether, these data demonstrate that Cdk5 plays a pivotal role in tau phosphorylation, cell cycle induction, synaptotoxicity, and apoptotic death in postmitotic neurons exposed to Aβ peptides in vivo , acting as a link between diverse neurotoxic pathways of AD.     

Phosphorylation of Cyclin-dependent Kinase 5 (Cdk5) at Tyr-15 Is Inhibited by Cdk5 Activators and Does Not Contribute to the Activation of Cdk5

Cdk5 is a member of the cyclin-dependent kinase (Cdk) family. In contrast to other Cdks that promote cell proliferation, Cdk5 plays a role in regulating various neuronal functions, including neuronal migration, synaptic activity, and neuron death. Cdks responsible for cell proliferation need phosphorylation in the activation loop for activation in addition to binding a regulatory subunit cyclin. Cdk5, however, is activated only by binding to its activator, p35 or p39. Furthermore, in contrast to Cdk1 and Cdk2, which are inhibited by phosphorylation at Tyr-15, the kinase activity of Cdk5 is reported to be stimulated when phosphorylated at Tyr-15 by Src family kinases or receptor-type tyrosine kinases. We investigated the activation mechanism of Cdk5 by phosphorylation at Tyr-15. Unexpectedly, however, it was found that Tyr-15 phosphorylation occurred only on monomeric Cdk5, and the coexpression of activators, p35/p25, p39, or Cyclin I, inhibited the phosphorylation. In neuron cultures, too, the activation of Fyn tyrosine kinase did not increase Tyr-15 phosphorylation of Cdk5. Further, phospho-Cdk5 at Tyr-15 was not detected in the p35-bound Cdk5. In contrast, expression of active Fyn increased p35 in neurons. These results indicate that phosphorylation at Tyr-15 is not an activation mechanism of Cdk5 but, rather, indicate that tyrosine kinases could activate Cdk5 by increasing the protein amount of p35. These results call for reinvestigation of how Cdk5 is regulated downstream of Src family kinases or receptor tyrosine kinases in neurons, which is an important signaling cascade in a variety of neuronal activities.